Marc Peschanski
Overview
Explore the profile of Marc Peschanski including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
102
Citations
2572
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
21.
Laustriat D, Gide J, Barrault L, Chautard E, Benoit C, Auboeuf D, et al.
Mol Ther Nucleic Acids
. 2015 Nov;
4:e262.
PMID: 26528939
Major physiological changes are governed by alternative splicing of RNA, and its misregulation may lead to specific diseases. With the use of a genome-wide approach, we show here that this...
22.
Georges P, Boissart C, Poulet A, Peschanski M, Benchoua A
Stem Cells
. 2015 Aug;
33(12):3666-72.
PMID: 26299682
Human pluripotent stem cell-derived neural stem cells offer unprecedented opportunities for producing specific types of neurons for several biomedical applications. However, to achieve it, protocols of production and amplification of...
23.
Peric D, Barragan I, Giraud-Triboult K, Egesipe A, Meyniel-Schicklin L, Cousin C, et al.
Stem Cells
. 2015 Jul;
33(10):2936-48.
PMID: 26184566
Statin treatment of hypercholesterolemia can lead to chronic myotoxicity which is, in most cases, alleviated by drug withdrawal. Cellular and molecular mechanisms of this adverse effect have been elusive, in...
24.
Allouche J, Bellon N, Saidani M, Stanchina-Chatrousse L, Masson Y, Patwardhan A, et al.
Proc Natl Acad Sci U S A
. 2015 Jul;
112(29):9034-9.
PMID: 26150484
"Café-au-lait" macules (CALMs) and overall skin hyperpigmentation are early hallmarks of neurofibromatosis type 1 (NF1). One of the most frequent monogenic diseases, NF1 has subsequently been characterized with numerous benign...
25.
Peschanski M, Bergeron M, Boue A, Coppens Y, Changeux J, Corvol P, et al.
Med Sci (Paris)
. 2015 Jun;
31 Spec No 1:47-90.
PMID: 26038812
No abstract available.
26.
Kahn A, Bergeron M, Gros F, Lhoste J, Peschanski M, Glorieux F, et al.
Med Sci (Paris)
. 2015 Jun;
31 Spec No 1:27-46.
PMID: 26038811
No abstract available.
27.
Wilmut I, Leslie S, Martin N, Peschanski M, Rao M, Trounson A, et al.
Regen Med
. 2015 May;
10(3):235-8.
PMID: 25933231
No abstract available.
28.
Maury Y, Come J, Piskorowski R, Salah-Mohellibi N, Chevaleyre V, Peschanski M, et al.
Nat Biotechnol
. 2014 Nov;
33(1):89-96.
PMID: 25383599
Specification of cell identity during development depends on exposure of cells to sequences of extrinsic cues delivered at precise times and concentrations. Identification of combinations of patterning molecules that control...
29.
Gocht T, Berggren E, Ahr H, Cotgreave I, Cronin M, Daston G, et al.
ALTEX
. 2014 Nov;
32(1):9-24.
PMID: 25372315
SEURAT-1 is a European public-private research consortium that is working towards animal-free testing of chemical compounds and the highest level of consumer protection. A research strategy was formulated based on...
30.
Blondel S, Jaskowiak A, Egesipe A, Le Corf A, Navarro C, Cordette V, et al.
Stem Cells Transl Med
. 2014 Mar;
3(4):510-9.
PMID: 24598781
Hutchinson-Gilford progeria syndrome is a rare congenital disease characterized by premature aging in children. Identification of the mutation and related molecular mechanisms has rapidly led to independent clinical trials testing...